Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05703386 · ClinicalTrials.gov registry record

Imaging the Pathogenesis of Cerebral Small Vessel Disease

A clinical trial of Hypertension and Diabetes, sponsored by Johns Hopkins University.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT05703386: Recruiting study of Hypertension and Diabetes, sponsored by Johns Hopkins University.

NCT05703386 is a study of Hypertension and Diabetes that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05703386, a study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use serial MRI scanning to gain insights into the pathogenesis of CSVD.

Primary Outcome

Conversion of normal appearing white matter to white matter hyperintensity measured on MRI using 3D FLAIR imaging.

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-11-08
Est. Completion 2027-03-31
Johns Hopkins University

1,448 total trials

What NCT05703386 shows while recruiting

NCT05703386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT05703386 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05703386 about?

NCT05703386 is a clinical study titled "Imaging the Pathogenesis of Cerebral Small Vessel Disease". Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use se...

What is the current status of trial NCT05703386?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-11-08. Estimated completion is 2027-03-31.

What conditions does trial NCT05703386 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Ischemic Stroke, Hyperlipidemias.

Who is sponsoring clinical trial NCT05703386?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05703386 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05703386's enrollment target sits among peer trials

50 367th of 470 higher than 96 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05703386, the US trial registry maintained by the National Library of Medicine. NCT05703386 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.